Chronic Kidney Disease Patient in Chronic Myloied Leukemia

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorSahar Mohammed Gad

About this trial

To study the Prevalence ,Characteristics and outcome of CKD in patiants with chronic myeloid leukemia .

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

all sexes , adult , not diabetic , not known CKD before diagnosed of CML

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • Biobsy from kidney

    Device

    using tyrosine kinase inhibitors particulary imatinib in ttt CML patients

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Chronic Kidney Disease Patient in Chronic Myloied Leukemia

Using Non Invasive or invasive Methods and correlation between lab and radiological methods to find and a relation between CML and CKD and outcome.

Time frame
basline

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sahar Mohammed Gad

Lead sponsor

Assiut University

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: